BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Yellow Fever

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Yellow Fever:

Pubmed Logo
DIFFERENTIAL CHOLESTEROL BINDING BY CLASS II FUSION PROTEINS DETERMINES MEMBRANE FUSION PROPERTIES.
The class II fusion proteins of the alphaviruses and flaviviruses mediate...
18th July, 2008
Department of Cell Biology, Albert Einstein College of Medicine, 1300 J Virol. 2008 Jul 16;.
DOI Direct Link
Antiviral activity of geneticin against bovine viral diarrhoea virus.
BACKGROUND: Aminoglycoside G418 is commonly used to generate stable...
17th July, 2008
Institute of Hepatitis and Viral Research, Doylestown, PA 18902, USA. Antivir Chem Chemother. 2008;19(1):33-40.
Evidence for interferon production and its correlation with YF 17DD vaccine virus yields in primary chick embryo cells.
Early experiments have resulted in the establishment of an efficient...
16th July, 2008
Fundacao Oswaldo Cruz, Instituto de Tecnologia em Virus Res. 2008 Jul 10;.
DOI Direct Link
Viral hemorrhagic Fever-induced acute kidney injury.
Viral hemorrhagic fevers (VHFs) are diseases caused by the RNA virus from...
16th July, 2008
Division of Nephrology, Sao Jose do Rio Preto Medical School, Sao Jose do Semin Nephrol. 2008 Jul;28(4):409-15.
DOI Direct Link
The enigma of yellow fever in East Africa.
Despite a safe and effective vaccine, there are approximately 200 000...
11th July, 2008
Department of Tropical Medicine, Tulane University, New Orleans, LA, USA. Rev Med Virol. 2008 Jul 10;.
DOI Direct Link

View more research publications.

BioNews Results for Yellow Fever:

RSS Logo
BioPortfolio Logo
Sagent Pharmaceuticals Launches Ceftriaxone, USP, And Cefuroxime For Injection, USP
Pharmaceutical Online:  Jul 17 2008 1:24PM Matching: yellow fever
Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP
KRON4:  Jul 16 2008 5:02PM Matching: yellow fever
Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP
Financials.com:  Jul 16 2008 2:33PM Matching: yellow fever
Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP
KOTA Territory News:  Jul 16 2008 1:08PM Matching: yellow fever
Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP
Columbus Business First:  Jul 16 2008 12:06PM Matching: yellow fever
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Yellow Fever Clinical Trials:

Clinical Trials Logo
Human Immune Responses to The Yellow Fever Virus Vaccine
Yellow Fever

Yellow Fever Patents:

USPTO Logo
US Patent No.Title
7364869 Method of detecting antigen-specific T lymphocytes
7371822 Human G-protein coupled receptor variant of HM74, HGPRBMY74
7371850 Method and composition for reducing expression of ROCK-II
7374779 Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
7375180 Methods and compositions related to IRM compounds and Toll-like receptor 8

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Yellow Fever scientists - we have details of around 338 individuals working on Yellow Fever .


This page has been viewed 155 times
Recent Search Terms used to find this page: yellow fever vacc dorset | remicade and yellow fever vaccine | yellow fever 2008 | patents for yellow fever | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Yellow Fever across BioPortfolio, or bestselling Yellow Fever books or recently published Yellow Fever books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional